Key Takeaways
- Medication-assisted treatment is the gold-standard for opioid addiction, combining medication with behavioral therapy.
- Buprenorphine is increasingly available through office-based providers and telehealth, expanding Arizona access.
- Methadone clinics provide intensive structure for individuals with complex needs.
- Naltrexone offers an alternative for individuals seeking lower-structure treatment or transitioning from other MAT.
- Integrated treatment combining medication with counseling produces optimal outcomes.
- Long-term MAT may be appropriate for many individuals, preventing relapse and overdose risk.
Understanding Medication-Assisted Treatment (MAT)
Medication-assisted treatment combines FDA-approved medications with behavioral therapy and psychosocial support to treat opioid use disorder. MAT reduces cravings, prevents withdrawal, improves treatment retention, and significantly reduces overdose risk.
Research consistently demonstrates MAT's effectiveness. The combination of medication managing the biological aspects of addiction with therapy addressing behavioral and social factors creates optimal treatment outcomes. Arizona providers increasingly recognize MAT as essential treatment for opioid addiction.
MAT efficacy: Research shows 60-80% of individuals in MAT reduce or stop illicit opioid use, compared to 10-20% in treatment without medication.
How MAT Works in the Brain
Opioid use disorder involves brain changes making the person vulnerable to cravings, withdrawal, and relapse. MAT medications address these neurobiological changes, stabilizing the brain's chemistry and reducing compulsive substance-seeking behavior.
Unlike simply stopping opioids (which causes severe withdrawal), MAT provides a medically supervised pathway allowing the brain to heal while reducing overdose risk.
Buprenorphine Treatment in Arizona
Buprenorphine is a partial opioid agonist effective for opioid use disorder. Unlike full opioids, buprenorphine has a ceiling effect on respiratory depression, making it safer than methadone. Office-based buprenorphine treatment has expanded access across Arizona.
Many Arizona primary care providers, addiction specialists, and community health centers offer buprenorphine. Telehealth buprenorphine treatment enables rural Arizonans to access this medication from home.
Buprenorphine advantages: Safer than methadone, office-based dispensing increases access, minimal overdose risk, and reduced street diversion potential.
Buprenorphine Dosing and Duration
Buprenorphine is typically dosed 4-24mg daily, individualized to each patient's needs. Treatment duration varies, with many patients remaining on buprenorphine long-term (months to years) to maintain stability.
Some patients eventually taper buprenorphine successfully, while others benefit from ongoing maintenance. Duration should reflect individual readiness and relapse risk.
Accessing Buprenorphine in Arizona
Search SAMHSA's buprenorphine provider database, ask your doctor for referrals, or contact addiction treatment programs. Many Arizona providers offer buprenorphine in-person and through telehealth.
Insurance usually covers buprenorphine. For uninsured individuals, sliding-scale clinics and community health centers provide treatment.
Methadone Programs in Arizona
Methadone is a full opioid agonist preventing withdrawal and reducing cravings. Methadone programs require daily or near-daily clinic attendance for medication dispensing and counseling, providing intensive treatment structure.
Arizona's major cities have methadone clinics. While rural access is limited compared to buprenorphine, methadone remains an important option for some individuals.
Methadone considerations: Effective but requires daily clinic attendance. Better for individuals benefiting from intensive structure and supervision.
Methadone Clinic Requirements
Methadone is dispensed through regulated clinics, not doctor's offices. Patients attend clinic regularly (often daily initially) for medication dose, counseling, and regular assessments.
Clinic structure provides intensive support and supervision, beneficial for individuals with complex needs or high relapse risk.
Naltrexone Treatment (Vivitrol)
Naltrexone is an opioid antagonist blocking opioid effects and reducing cravings. Extended-release naltrexone (Vivitrol) is injected monthly, eliminating daily medication needs.
Naltrexone is less commonly used than buprenorphine or methadone but provides an option for individuals wanting reduced treatment structure or those who have completed buprenorphine or methadone treatment.
Naltrexone benefits: Monthly injections reduce daily medication burden. Useful for individuals ready to taper from other MAT or seeking lower-structure treatment.
Integrating MAT with Behavioral Therapy
MAT is most effective when combined with behavioral therapy, counseling, support groups, and psychosocial services. Medication stabilizes the biological aspects while therapy addresses behavioral and social factors.
Quality MAT programs include individual counseling, group therapy, psychiatric services, case management, and peer support alongside medication treatment.
Integrated approach: Medication alone is insufficient. Counseling and psychosocial support are essential for optimal MAT outcomes. Call (949) 280-8360 to learn about comprehensive MAT programs.
Counseling and Therapy in MAT
Therapists help individuals understand triggers, develop coping skills, address trauma or mental health issues, rebuild relationships, and develop new identities beyond addiction.
Regular therapy creates accountability, provides relapse prevention strategies, and addresses underlying issues driving opioid use.
Medical Review Board, MD, ABAM
Medical Director & Reviewer
